Prognostic value of clinical, laboratory, and histological characteristics in multiple myeloma: improved definition of risk groups.

Peest, D; Coldewey, R; Deicher, H; Sailer, M; Vykoupil, C; Leo, R; Georgii, A; Karow, J; Hoeppner, E; Diehl, V

Peest, D; Coldewey, R; Deicher, H; Sailer, M; Vykoupil, C; Leo, R; Georgii, A; Karow, J; Hoeppner, E; Diehl, V.

Affiliation

Peest D; Abt. Immunologie und Transfusionsmedizin, Zentrum Innere Medizin und Dermatologie, Medizinische Hochschule Hannover, F.R.G.

Eur J Cancer ; 29A(7): 978-83, 1993.

Article in En | MEDLINE | ID: mdl-8499152

Subject(s)

Multiple Myeloma/mortality; Bone Marrow/pathology; Calcium/blood; Hemoglobins/analysis; Humans; Multiple Myeloma/blood; Multiple Myeloma/drug therapy; Multiple Myeloma/pathology; Multivariate Analysis; Platelet Count; Predictive Value of Tests; Prognosis; Risk Factors; Time Factors

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Multiple Myeloma Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Eur J Cancer Year: 1993 Document type: Article Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links